EVERETT LABORATORIES, INC. — TTAB Proceedings
EVERETT LABORATORIES, INC. is a party to 3 TTAB proceedings.
Proceedings
- Proceeding 85515780 — Extensions of Time to Oppose, Terminated (filed 2013-01-16) against Glaxo Group Limited as defendant
- Proceeding 91159154 — Oppositions, Terminated (filed 2004-01-21) against Breckenridge Pharmaceutical, Inc. as defendant
- Proceeding 76463772 — Extensions of Time to Oppose, Terminated (filed 2003-12-22) against Breckenridge Pharmaceutical, Inc. as defendant
Marks in These TTAB Matters
Common TTAB Counterparties
- Breckenridge Pharmaceutical, Inc. — 2 proceedings
- Glaxo Group Limited — 1 proceedings
Recent TTAB Timeline
- 2013-01-16: 85515780 — EXTENSION OF TIME GRANTED involving Glaxo Group Limited
- 2013-01-16: 85515780 — INCOMING - EXT TIME TO OPPOSE FILED involving Glaxo Group Limited
- 2005-04-09: 91159154 — TERMINATED involving Breckenridge Pharmaceutical, Inc.
- 2005-04-09: 91159154 — BOARD'S DECISION: DISMISSED involving Breckenridge Pharmaceutical, Inc.
- 2005-03-17: 91159154 — WITHDRAWAL OF OPPOSITION involving Breckenridge Pharmaceutical, Inc.
- 2004-11-09: 91159154 — SUBMITTED ON BRIEF involving Breckenridge Pharmaceutical, Inc.
- 2004-08-09: 91159154 — SUBMITTED ON BRIEF involving Breckenridge Pharmaceutical, Inc.
- 2004-08-06: 91159154 — SUBMITTED ON BRIEF involving Breckenridge Pharmaceutical, Inc.
- 2004-08-03: 91159154 — SUBMITTED ON BRIEF involving Breckenridge Pharmaceutical, Inc.
- 2004-07-13: 91159154 — SUBMITTED ON BRIEF involving Breckenridge Pharmaceutical, Inc.
- 2004-03-02: 91159154 — ANSWER involving Breckenridge Pharmaceutical, Inc.
- 2004-01-22: 91159154 — PENDING, INSTITUTED involving Breckenridge Pharmaceutical, Inc.
- 2004-01-22: 91159154 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Breckenridge Pharmaceutical, Inc.
- 2004-01-21: 91159154 — FILED AND FEE involving Breckenridge Pharmaceutical, Inc.
- 2003-12-23: 76463772 — EXTENSION OF TIME GRANTED involving Breckenridge Pharmaceutical, Inc.
- 2003-12-23: 76463772 — INCOMING - EXT TIME TO OPPOSE FILED involving Breckenridge Pharmaceutical, Inc.